Elevance Health (ELV) announced management changes “designed to simplify decision-making and strengthen execution across Carelon and Health Benefits.” As part of these changes, Mark Kaye, executive VP and CFO, will expand his responsibilities to include oversight of Carelon, the company’s healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. Felicia Norwood, executive VP and Chief Health Benefits Officer, will assume responsibility for the company’s consolidated Health Benefits organization, bringing together the company’s major Health Benefits businesses and core operating functions under a single accountable structure. Peter Haytaian has announced that he will transition from his role as executive VP and president of Carelon effective May 4, in order to devote more time to family commitments. Haytaian will serve the company as Special Advisor through December 31, to support an orderly leadership transition and ensure continuity across Carelon’s operations and client and partner relationships.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- DELL, SPOT, UNH: The World’s Biggest Hedge Fund Is Bottom Fishing the Market
- CVS, ELV, CNC: Health Insurer Stocks Under Pressure as U.S. Expands Fraud Probe
- Subpoenas issued to eight health insurers by House panel, Axios reports
- Molina Healthcare Stock (MOH) Plunges on Dismal Earnings Outlook, Drags Down Shares of Peers UNH and CNC
- Adobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
